Supplementary Figure Legend from Maintained Sensitivity to EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Lung Cancer Recurring after Adjuvant Erlotinib or Gefitinib
Authors:
- Geoffrey R. OxnardGOGeoffrey R. Oxnard
- Yelena Y. JanjigianYJYelena Y. Janjigian
- Maria E. ArcilaMAMaria E. Arcila
- Camelia S. SimaCSCamelia S. Sima
- Samantha L. KassSKSamantha L. Kass
- Gregory J. RielyGRGregory J. Riely
- William PaoWPWilliam Pao
- Mark G. KrisMKMark G. Kris
- Marc LadanyiMLMarc Ladanyi
- Christopher G. AzzoliCAChristopher G. Azzoli
- Vincent A. MillerVMVincent A. Miller
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)